Finance

Lists
TXG:NASDAQ
10X Genomics Inc
90,27 US$
-0,10%
(-0,088) 1D
1 ოქტ, 12:43:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TXG...
Open
89,30 US$
High
92,92 US$
Low
88,60 US$
Mkt. cap
11,76 მლრდ.
Avg. vol.
3,02 მლნ.
Volume
1,32 მლნ.
52-wk high
95,16 US$
52-wk low
11,16 US$
EPS
-0,59 US$
Beta
2,08
Shares outstanding
120,21 მლნ.
No. of employees
1 ათ.
Open
89,30 US$
High
92,92 US$
Low
88,60 US$
Mkt. cap
11,76 მლრდ.
Avg. vol.
3,02 მლნ.
Volume
1,32 მლნ.
52-wk high
95,16 US$
52-wk low
11,16 US$
EPS
-0,59 US$
Beta
2,08
Shares outstanding
120,21 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Trefis
Trefis
·
7 საათის წინ
5 Green Days In A Row: 10x Genomics Stock Is Up 20%
Yahoo Finance
Yahoo Finance
·
3 დღის წინ
10x Genomics, Inc. (TXG) Stock Forecasts
Profile
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics. Wikipedia
About 10X Genomics Inc
CEOსერჟ სახონოვი
Employees1,18 ათ.
Founded2012
HeadquartersPleasanton, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth care
Analyst ratings
Based on 16 analysts giving stock ratings to TXG in the past 3 months
Buy
Buy
7
Hold
9
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for TXG in the last 3 months.
Highest
Current 90,27 US$
110,00 US$ (+21,85%)
Average
63,21 US$ (-29,98%)
Lowest
40,00 US$ (-55,69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Larew
William Blair
Buy
Maintained
-
-
09/29/2026
Puneet Souda
Leerink Partners
Hold
Maintained
90,00 US$
-0,3%
09/29/2026
David Westenberg
Piper Sandler
Hold
Reiterated
80,00 US$
-11,4%
09/28/2026
Unknown Analyst
Argus Research
Buy
Initiated
110,00 US$
+21,9%
09/28/2026
John Eade
Argus Research
Buy
Initiated
110,00 US$
+21,9%
09/25/2026
Unknown Analyst
UBS
Hold
Initiated
68,00 US$
-24,7%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
68,00 US$
-24,7%
09/09/2026
Dan Leonard
RBC Capital
Hold
Initiated
70,00 US$
-22,5%
09/01/2026
Unknown Analyst
Stephens
Buy
Reiterated
65,00 US$
-28%
08/12/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
50,00 US$
-44,6%
08/10/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
50,00 US$
-44,6%
08/11/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
60,00 US$
-33,5%
08/10/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Reiterated
40,00 US$
-55,7%
08/10/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
-
-
08/07/2026
Tycho Peterson
Jefferies
Buy
Reiterated
53,00 US$
-41,3%
08/07/2026
Patrick B Donnelly
Citi
Hold
Maintained
50,00 US$
-44,6%
08/07/2026
‏Brendan Digan‏
Citi
Hold
Maintained
50,00 US$
-44,6%
08/07/2026
Luke Sergott
Barclays
Buy
Maintained
52,00 US$
-42,4%
08/06/2026
Daniel Brennan
TD Cowen
Hold
Maintained
47,00 US$
-47,9%
07/15/2026
Justin Bowers
Deutsche Bank
Hold
Maintained
23,00 US$
-74,5%
05/08/2026
Last report
6 აგვ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
0,03 US$ / -0,02 US$
+258,37%beat
Revenue / Est. (USD)
151,04 მლნ. / 146,62 მლნ.
+3,01%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
149,00 მლნ.
166,03 მლნ.
150,84 მლნ.
151,04 მლნ.
Cost of goods sold
48,70 მლნ.
52,88 მლნ.
44,66 მლნ.
38,54 მლნ.
Cost of revenue
48,70 მლნ.
52,88 მლნ.
44,66 მლნ.
38,54 მლნ.
Research and development expenses
57,19 მლნ.
55,77 მლნ.
56,85 მლნ.
56,79 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
74,66 მლნ.
73,02 მლნ.
66,38 მლნ.
78,66 მლნ.
Operating expense
131,85 მლნ.
128,79 მლნ.
123,22 მლნ.
135,45 მლნ.
Total operating expenses
180,54 მლნ.
181,67 მლნ.
167,89 მლნ.
173,99 მლნ.
Operating income
-31,54 მლნ.
-15,64 მლნ.
-17,05 მლნ.
-22,96 მლნ.
Other non operating income
538,00 ათ.
-3,04 მლნ.
-72,00 ათ.
-3,49 მლნ.
EBT including unusual items
-28,20 მლნ.
-15,19 მლნ.
-12,85 მლნ.
-18,64 მლნ.
EBT excluding unusual items
-26,40 მლნ.
-12,39 მლნ.
-12,90 მლნ.
-22,04 მლნ.
Income tax expense
-733,00 ათ.
1,06 მლნ.
623,00 ათ.
-714,00 ათ.
Effective tax rate
2,60%
-6,97%
-4,85%
3,83%
Other operating expenses
-
-
-
-
Net income
-27,47 მლნ.
-16,25 მლნ.
-13,47 მლნ.
-17,93 მლნ.
Net profit margin
-18,44%
-9,79%
-8,93%
-11,87%
Earnings per share
-0,02
0,07
0,07
0,03
Interest and investment income
5,20 მლნ.
6,89 მლნ.
5,01 მლნ.
4,80 მლნ.
Interest expense
-
-
-
-
Net interest expenses
5,20 მლნ.
6,89 მლნ.
5,01 მლნ.
4,80 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,24 მლნ.
-5,58 მლნ.
-7,09 მლნ.
-13,29 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები